Description
This is a 10mg lyophilized vial of dual GIP/GLP-1 agonist peptide, ≥99% HPLC purity, shipped from Canada for research use only.
Higher concentration for extended protocols
This vial holds twice the peptide content of the 5mg version, which suits researchers running longer study timelines or needing higher working concentrations. It is the same compound, just more of it per vial.
Dual receptor activity for metabolic research
The compound acts on both GIP and GLP-1 receptor pathways at once. This dual agonism is studied for its combined effects on insulin secretion, glucagon activity, adipose tissue, and appetite regulation.
Verified purity with batch documentation
Each batch is HPLC-tested to confirm purity of 99% or higher, and a Certificate of Analysis is available on request. The peptide arrives as a lyophilized white powder that needs reconstitution before use in research settings.
Specifications
| Attribute | Details |
|---|---|
| Active Compound | Dual GIP/GLP-1 Agonist |
| Chemical Classification | 39-AA Dual Agonist |
| Amount Per Vial | 10mg (10000 mcg) |
| Form | Lyophilized White Powder |
| Purity | ≥99% (HPLC Verified) |
| Half-Life | ~5 days |
| Storage (Unreconstituted) | -20°C long-term, 2-8°C short-term |
| Storage (Reconstituted) | Refrigerated 2-8°C, use within 28-60 days |
| Shelf Life | 24 months unreconstituted when stored properly |
| Shipping | Discreet plain packaging, ships from Canada |
| COA | Available on request for every batch |
Research Use Only. Not approved by Health Canada for human or veterinary use. For qualified researchers only.
